FR2287901B1 - - Google Patents

Info

Publication number
FR2287901B1
FR2287901B1 FR7434400A FR7434400A FR2287901B1 FR 2287901 B1 FR2287901 B1 FR 2287901B1 FR 7434400 A FR7434400 A FR 7434400A FR 7434400 A FR7434400 A FR 7434400A FR 2287901 B1 FR2287901 B1 FR 2287901B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7434400A
Other languages
French (fr)
Other versions
FR2287901A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR7434400A priority Critical patent/FR2287901A1/fr
Priority to CA237,426A priority patent/CA1063052A/en
Priority to GB41872/75A priority patent/GB1530138A/en
Priority to ZA00756462A priority patent/ZA756462B/xx
Priority to AU85703/75A priority patent/AU8570375A/en
Priority to NL7512053A priority patent/NL7512053A/xx
Priority to IL48293A priority patent/IL48293A/xx
Priority to DE2546001A priority patent/DE2546001C3/de
Priority to BE160922A priority patent/BE834493A/xx
Publication of FR2287901A1 publication Critical patent/FR2287901A1/fr
Application granted granted Critical
Publication of FR2287901B1 publication Critical patent/FR2287901B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/207Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7434400A 1974-10-14 1974-10-14 Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle Granted FR2287901A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR7434400A FR2287901A1 (fr) 1974-10-14 1974-10-14 Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle
CA237,426A CA1063052A (en) 1974-10-14 1975-10-10 Immunostimulant drug containing phosphorylated ose or polyose derivatives
ZA00756462A ZA756462B (en) 1974-10-14 1975-10-13 Phospholipide immunostimulant
GB41872/75A GB1530138A (en) 1974-10-14 1975-10-13 Pharmaceutical composition
AU85703/75A AU8570375A (en) 1974-10-14 1975-10-14 Phospholipide immunostimulant
NL7512053A NL7512053A (nl) 1974-10-14 1975-10-14 Gefosforyleerde ose- of polyoseverbindingen, en geneesmiddelen met dergelijke verbindingen.
IL48293A IL48293A (en) 1974-10-14 1975-10-14 Pharmaceutical compositions containing glyceryl esters of a phosphorylated ose or polyose
DE2546001A DE2546001C3 (de) 1974-10-14 1975-10-14 Immunostimulierende, Phospholipide enthaltende Stoffgemische, diese Stoffgemische enthaltende Arzneimittel und Verfahren zu ihrer Gewinnung
BE160922A BE834493A (fr) 1974-10-14 1975-10-14 Phospholipides immunostimulants contenant un derive d'ose ou de polyose phosphoryle et medicaments les contenant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7434400A FR2287901A1 (fr) 1974-10-14 1974-10-14 Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle

Publications (2)

Publication Number Publication Date
FR2287901A1 FR2287901A1 (fr) 1976-05-14
FR2287901B1 true FR2287901B1 (ru) 1978-07-21

Family

ID=9144037

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7434400A Granted FR2287901A1 (fr) 1974-10-14 1974-10-14 Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle

Country Status (9)

Country Link
AU (1) AU8570375A (ru)
BE (1) BE834493A (ru)
CA (1) CA1063052A (ru)
DE (1) DE2546001C3 (ru)
FR (1) FR2287901A1 (ru)
GB (1) GB1530138A (ru)
IL (1) IL48293A (ru)
NL (1) NL7512053A (ru)
ZA (1) ZA756462B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2046092B (en) 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4585762A (en) * 1982-07-30 1986-04-29 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, processes for use thereof and pharmaceutical composition of the same
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
FR2596651B1 (fr) * 1986-04-08 1989-11-10 Centre Nat Rech Scient Nouveaux liposomes a base de phosphatidylinositolmannosides, et compositions pharmaceutiques les contenant
IT1244546B (it) * 1991-02-01 1994-07-15 Mediolanum Farmaceutici Spa Analoghi del fosfatidilinositolo inibitori della fosfolipasi c fosfatidilinositolo-specifica
IT1248012B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793260A (fr) * 1971-12-24 1973-06-22 Pasteur Institut Agent immunostimulant, medicaments le contenant et procede de fabrication de cet agent immunostimulant

Also Published As

Publication number Publication date
AU8570375A (en) 1977-04-21
GB1530138A (en) 1978-10-25
DE2546001C3 (de) 1980-06-19
ZA756462B (en) 1976-09-29
FR2287901A1 (fr) 1976-05-14
DE2546001B2 (de) 1979-07-19
DE2546001A1 (de) 1976-04-15
BE834493A (fr) 1976-04-14
NL7512053A (nl) 1976-04-20
IL48293A0 (en) 1975-12-31
CA1063052A (en) 1979-09-25
IL48293A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
FR2287901B1 (ru)
FR2282901B1 (ru)
FR2265239A1 (ru)
FR2276286B1 (ru)
AU495930B2 (ru)
FR2278265B1 (ru)
FR2289108B3 (ru)
BG21351A1 (ru)
BG22040A1 (ru)
BG20446A1 (ru)
BG20440A1 (ru)
BG19987A1 (ru)
BG19847A1 (ru)
BG20462A1 (ru)
BG19768A1 (ru)
BG20638A1 (ru)
AU480863A (ru)
AU480758A (ru)
AU480471A (ru)
AU480247A (ru)
AU480208A (ru)
AU479931A (ru)
AU479765A (ru)
BG21307A1 (ru)
BG22586A1 (ru)

Legal Events

Date Code Title Description
ST Notification of lapse